User profiles for J M Unger
Joseph M Unger, PhD, MSFred Hutchinson Cancer Research Center Verified email at fredhutch.org Cited by 17737 |
Human capital and entrepreneurial success: A meta-analytical review
The study meta-analytically integrates results from three decades of human capital research
in entrepreneurship. Based on 70 independent samples (N=24,733), we found a significant …
in entrepreneurship. Based on 70 independent samples (N=24,733), we found a significant …
The role of clinical trial participation in cancer research: barriers, evidence, and strategies
JM Unger, E Cook, E Tai, A Bleyer - American Society of Clinical …, 2016 - ascopubs.org
Fewer than one in 20 adult patients with cancer enroll in cancer clinical trials. Although barriers
to trial participation have been the subject of frequent study, the rate of trial participation …
to trial participation have been the subject of frequent study, the rate of trial participation …
Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation
… Joseph M Unger , Joseph M Unger … Unger, PhD, MS, Fred Hutchinson Cancer
Research Center, 1100 Fairview Ave N, M3-C102, PO Box19024, Seattle, WA 98109-1024 (junger@…
Research Center, 1100 Fairview Ave N, M3-C102, PO Box19024, Seattle, WA 98109-1024 (junger@…
[HTML][HTML] Underrepresentation of patients 65 years of age or older in cancer-treatment trials
LF Hutchins, JM Unger, JJ Crowley… - … England Journal of …, 1999 - Mass Medical Soc
Background Studies have documented the underrepresentation of women and blacks in
clinical trials, and their recruitment is now federally mandated. However, little is known about …
clinical trials, and their recruitment is now federally mandated. However, little is known about …
[HTML][HTML] Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy
HCF Moore, JM Unger, KA Phillips… - … England Journal of …, 2015 - Mass Medical Soc
Background Ovarian failure is a common toxic effect of chemotherapy. Studies of the use of
gonadotropin-releasing hormone (GnRH) agonists to protect ovarian function have shown …
gonadotropin-releasing hormone (GnRH) agonists to protect ovarian function have shown …
Entrepreneurial orientation: A psychological model of success among southern African small business owners
…, M Frese, C Friedrich, JM Unger - European journal of work …, 2005 - Taylor & Francis
This study examines the relationship of the psychological construct Entrepreneurial Orientation
(EO) with business success in a sample of N = 248 southern African business owners. …
(EO) with business success in a sample of N = 248 southern African business owners. …
Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018
Importance Representative racial/ethnic participation in research, especially in clinical trials
that establish standards of care, is necessary to minimize disparities in outcomes and to …
that establish standards of care, is necessary to minimize disparities in outcomes and to …
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group
KS Albain, JM Unger, JJ Crowley… - JNCI: Journal of the …, 2009 - academic.oup.com
Background Racial disparities in cancer outcomes have been observed in several
malignancies. However, it is unclear if survival differences persist after adjusting for clinical, …
malignancies. However, it is unclear if survival differences persist after adjusting for clinical, …
New treatment options have changed the survival of patients with follicular lymphoma
…, OW Press, DG Maloney, JM Unger… - Journal of Clinical …, 2005 - ascopubs.org
Background The natural history of follicular lymphoma is believed not to have changed over
the last 30 years. Median survivals have ranged from 7 to 10 years, and the disease is …
the last 30 years. Median survivals have ranged from 7 to 10 years, and the disease is …
[HTML][HTML] Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma
Background The efficacy of autologous stem-cell transplantation during the first remission in
patients with diffuse, aggressive non-Hodgkin's lymphoma classified as high-intermediate …
patients with diffuse, aggressive non-Hodgkin's lymphoma classified as high-intermediate …